Member Info for sphinx100

I’ve read this before

“

Post-Market Surveillance: Even after conditional approval, products are subject to a five-year post-market surveillance period. Successful completion of this phase is necessary for the health function to be formally recognized and included in the official directory.”

anyone like to comment!

Perhaps they are waiting for ff to be approved as a drug ! Then they can announce the whole ff claims to the world and the roll out across China’s 300m at risk people, I wonder what a daily dose would do for the overall cardiovascular health of the Chinese population!

Alf I’m not disagreeing with what you say , but what possible advantage would the government have for delaying a new product and function to hit the market !

to me a product like Fruitflow which has many proven claims and would be a driver of growth especially for By Health (which is going through a sticky patch at the moment) .

It seems to me that the bod of Pxs are waiting above all else for the SAMR approval ,and are reluctant to announce anything until it is approved, hence we have no news which is not good for the sp or long term holders . If the delay goes over 2 years then I would say you are probably right .just my opinion.

Sorry Mcnol RFA =

Yes agree with that , the only thing that puts my mind at rest is BH did buy out Lifespace for about £400 m , which in hindsight was quite a good deal for the owners of LS .

Hopefully Pxs could be worth a bit more , not sure if the big holders would be happy with that !

Alf are you referring to being taken out cheaply ! Or is there something else we should worry about !!

Looks like an isa transfer

But not Fruitflow I’m afraid . At least they’re working towards new functions .

“Aids in Maintaining Joint Health” Poised to Join China’s Health Function Catalog

Publication date：2025-04-24

China

Food

On April 24, 2025, China's State Administration for Market Regulation (SAMR) issued a public consultation on the draft "Catalog of Permitted Health Claims for Health Foods: Aids in Maintaining Joint Health." Stakeholders are invited to submit their feedback by June 2, 2025

SMAR health food announcement.png

This marks the first new health function proposed to be included in the official health claim catalog since the issuance of the “Implementation Rules for the Evaluation of New Health Functions and Product Technologies of Health Foods (Trial)”.

That was a month ago ,must be getting very close now !

If would interpret that as “ but excludes any transactions of a

revenue nature in the ordinary course of business and transactions to raise finance which

do not involve a change in the fixed assets of the AIM company or its subsidiaries.“

As of 30th Sept 2024 they had £478 k in the bank , they had the share issue to DSM probably £400k , the H2 income( which they kept secret) was maybe £800 .

That’s £1.7 m Maybe they won’t need to raise funding , but like you say wtfdik

Yes you would have thought so ,unfortunately I’m not sure IF has any intention of informing us about the production run , I’m not even sure if he has to tell shareholders sticking to AIM rules !

Enterprises to promote the use of dietary guidelines. (2) Optimize the supply of special food market, deepen the reform of special food registration and filing system, improve the pre-evaluation and post-evaluation mechanism of health food, and facilitate the review and registration of new functions and products of health food.

Https://www.moomoo.com/news/post/51497103/ping-an-securities-the-action-plan-for-promoting-healthy-consumerism?futusource=news_web_stockpagenews&lang=en-us&ns_stock_id=64239828146418&report_id=44812642&report_type=stock&src=43&stock_news_tab=news&global_content=%7B%22promote_id%22%3A13764%2C%22sub_promote_id%22%3A57%7D&level=1&data_ticket=1712713593151956

Have you tried a dummy buy/sell , I’ve often found the spread is much tighter than quoted .

Ok thanks for your replies

Does anyone know how the new company will work ! Will He1 and TG have equal shares in this new entity, and will it lead to a share split for existing shareholders, I have little insight into this .

if anyone with some real knowledge post there thinking it would be much appreciated by me and I suspect many on this board .

Does look like some manipulation going on , placing at .4p anyone!

Looks like someone’s getting in cheap !

From 1 January 2023 the Group's sales channels for Fruitflow therefore include:

1. Former DSM customers for Fruitflow;

2. DSM and its Premix and Market-Ready Solutions businesses, which will leverage the resources and relationships of DSM in some of the major global markets, and seek to commercialise the gut microbiome patent;

3. New customers for Fruitflow as a straight ingredient;

4. BYHEALTH and its customers, through the Company's long-term supply and distribution agreement for Fruitflow with BYHEALTH; and

5. The Group's Fruitflow+ Omega-3 dietary supplement product which is sold direct to consumers, the Group will also look to serve its Chinese Cross-Border e-commerce distributor for this product in China.